Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Motorcyclist Injured in Crash on 110 Freeway Near Imperial Highway


Motorcycle, Jeep Collide in Los Angeles Accident 

Los Angeles, CA (May 21, 2020) – A motorcyclist was injured in a crash in Los Angeles. The accident occurred on the morning of May 21 on the 110 Freeway.

A motorcyclist was riding on the 110 Freeway, near Imperial Highway, when they lost control and rear-ended a Jeep in front of them. The rider went down in the road. Three drivers stopped to assist the rider, including a nurse. The victim was injured and taken to a local hospital. 

#Los Angeles 

#90044


October 2, 2019

1 Killed in Crash at Monte Road and Avila Beach Drive

SUV Goes Down Embankment, Hits Tree in Fatal Avila Beach Accident Avila Beach, ...


January 14, 2020

1 Killed in Crash on Bear Valley Road

2 Vehicles Involved in Fatal Apple Valley Accident...


March 25, 2020

1 Killed in Crash at Sierra Avenue and Karen Lane

2 Vehicles Collide in Fatal Jurupa Valley Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.